High mortality among patients hospitalized for drug‐resistant tuberculosis with acquired second‐line drug resistance and high <scp>HIV</scp> prevalence-Reference-Cited by-同舟云学术

High mortality among patients hospitalized for drug‐resistant tuberculosis with acquired second‐line drug resistance and high HIV prevalence

Published:2022-05-24 Issue:10 Volume:23 Page:1085-1097
ISSN:1464-2662
Container-title:HIV Medicine
language:en
Short-container-title:HIV Medicine

Author:

Anderson Kim¹²^ORCID,Pietersen Elize¹,Shepherd Bryan E.³,Bian Aihua³,Dheda Keertan¹⁴⁵,Warren Robin⁶,Sterling Timothy R.⁷⁸,van der Heijden Yuri F.⁷⁸⁹

Affiliation:

1. Centre for Lung Infection and Immunity, Division of Pulmonology, Department of Medicine and UCT Lung Institute University of Cape Town Cape Town South Africa

2. Centre for Infectious Disease Epidemiology and Research, School of Public Health and Family Medicine University of Cape Town Cape Town South Africa

3. Department of Biostatistics Vanderbilt University School of Medicine Nashville Tennessee USA

4. South African MRC Centre for the Study of Antimicrobial Resistance University of Cape Town Cape Town South Africa

5. Faculty of Infectious and Tropical Diseases, Department of Infection Biology, London School of Hygiene and Tropical Medicine London UK

6. DST‐NRF Centre of Excellence for Biomedical Tuberculosis Research/SAMRC Centre for TB Research/Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences Stellenbosch University Tygerberg South Africa

7. Vanderbilt Tuberculosis Center Vanderbilt University School of Medicine Nashville Tennessee USA

8. Division of Infectious Diseases, Department of Medicine Vanderbilt University School of Medicine Nashville Tennessee USA

9. The Aurum Institute Johannesburg South Africa

Funder

European and Developing Countries Clinical Trials Partnership

National Institutes of Health

South African Medical Research Council

Medical Research Council

Wellcome Trust

Publisher

Wiley

Subject

Pharmacology (medical),Infectious Diseases,Health Policy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hiv.13318

Reference40 articles.

1. World Health Organization [Internet]. Global tuberculosis report 2020 [cited 2021 Oct 22]. Available from:https://www.who.int/publications/i/item/9789240013131

2. HIV infection and multidrug resistant tuberculosis: a systematic review and meta-analysis

3. The effect of human immunodeficiency virus infection on adverse events during treatment of drug-resistant tuberculosis: A systematic review and meta-analysis

4. Outcomes of HIV-infected versus HIV-non-infected patients treated for drug-resistance tuberculosis: Multicenter cohort study

5. Outcomes of Multidrug-Resistant Tuberculosis Treatment with Early Initiation of Antiretroviral Therapy for HIV Co-Infected Patients in Lesotho

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and emerging trends of drug resistance mutations in HIV: a bibliometric analysis based on CiteSpace;Frontiers in Microbiology;2024-05-15

2. Relationship between HIV viral suppression and multidrug resistant tuberculosis treatment outcomes;PLOS Global Public Health;2024-05-06

3. The clinical profile and outcomes of drug resistant tuberculosis in Central Province of Zambia;BMC Infectious Diseases;2024-04-01

4. Variation in missed doses and reasons for discontinuation of anti-tuberculosis drugs during hospital treatment for drug-resistant tuberculosis in South Africa;PLOS ONE;2023-02-13